F6Publishing

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Articles Published Processes

Keyword: Nonalcoholic steatohepatitis

Page 1 of 3 ( 121 items )
<<
1
2
3
>>

1	Clinicopathological characteristics and risk factors in nonalcoholic steatohepatitis patients with different stages of liver fibrosis 7/24/2026 7:03:49 AM \| Browse: 38 \| Download: 183
2	Noninvasive liver fibrosis assessment in metabolic dysfunction-associated steatotic liver disease 1/27/2026 10:12:30 AM \| Browse: 256 \| Download: 369
3	Quick glance at 'metabolic dysfunction associated steatotic liver disease' therapeutics: Targets, trials, and trends 12/5/2025 11:28:02 AM \| Browse: 197 \| Download: 453
4	Pathological features of non-alcoholic steatohepatitis in a pediatric patient with heterozygous familial hypobetalipoproteinemia: A case report 2/20/2025 8:39:54 AM \| Browse: 331 \| Download: 939
5	Revolutionizing the understanding of liver disease: Metabolism, function and future 11/29/2024 2:50:19 PM \| Browse: 395 \| Download: 1092
6	Regression of hepatic fibrosis after pharmacological therapy for nonalcoholic steatohepatitis 10/25/2024 3:02:15 AM \| Browse: 385 \| Download: 956
7	Potential therapeutic targets for nonalcoholic fatty liver disease: Glucagon-like peptide 1 12/27/2023 5:42:53 AM \| Browse: 549 \| Download: 1673
8	Noninvasive biomarkers in pediatric nonalcoholic fatty liver disease 5/24/2023 9:31:05 AM \| Browse: 652 \| Download: 1571
9	New uses for an old remedy: Digoxin as a potential treatment for steatohepatitis and other disorders 3/28/2023 12:59:29 PM \| Browse: 477 \| Download: 1194
10	Emerging role of engineered exosomes in nonalcoholic fatty liver disease 3/22/2023 11:20:34 AM \| Browse: 705 \| Download: 1795
11	Microbiome-liver crosstalk: A multihit therapeutic target for liver disease 3/17/2023 6:20:53 AM \| Browse: 576 \| Download: 1582
12	Hepatocellular carcinoma in non-alcoholic steatohepatitis without cirrhosis 1/6/2023 2:52:58 AM \| Browse: 722 \| Download: 1271
13	Screening and interventions to prevent nonalcoholic fatty liver disease/nonalcoholic steatohepatitis-associated hepatocellular carcinoma 1/6/2023 2:52:58 AM \| Browse: 730 \| Download: 1538
14	Management of metabolic-associated fatty liver disease: The diabetology perspective 1/4/2023 5:53:02 AM \| Browse: 681 \| Download: 1318
15	Emerging novel targets for nonalcoholic fatty liver disease treatment: Evidence from recent basic studies 1/4/2023 5:53:01 AM \| Browse: 698 \| Download: 1802
16	Dietary counseling based on artificial intelligence for patients with nonalcoholic fatty liver disease 10/28/2022 7:46:25 AM \| Browse: 925 \| Download: 2300
17	Heredity hemochromatosis: Temporal trends, sociodemographic characteristics, and independent risk factor of hepatocellular cancer – nationwide population-based study 9/23/2022 12:48:56 AM \| Browse: 868 \| Download: 2410
18	Nonalcoholic fatty liver disease and diabetes 9/9/2022 3:45:24 PM \| Browse: 1088 \| Download: 2014
19	Simple diagnostic algorithm identifying at-risk nonalcoholic fatty liver disease patients needing specialty referral within the United States 8/26/2022 9:51:35 AM \| Browse: 886 \| Download: 2109
20	Prognostic non-invasive biomarkers for all-cause mortality in non-alcoholic fatty liver disease: A systematic review and meta-analysis 5/24/2022 10:35:19 AM \| Browse: 840 \| Download: 1956
21	Hepatocellular carcinoma in patients with metabolic dysfunction-associated fatty liver disease: Can we stratify at-risk populations? 2/22/2022 9:25:37 AM \| Browse: 999 \| Download: 2275
22	Non-alcoholic steatohepatitis in liver transplant recipients diagnosed by serum cytokeratin 18 and transient elastography: A prospective study 12/27/2021 5:24:01 AM \| Browse: 1024 \| Download: 2500
23	Promising diagnostic biomarkers of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: From clinical proteomics to microbiome 11/24/2021 9:54:22 AM \| Browse: 1117 \| Download: 2230
24	Association of non-alcoholic fatty liver disease and COVID-19: A literature review of current evidence 8/20/2021 9:33:19 AM \| Browse: 1073 \| Download: 2336
25	PPARGC1A rs8192678 G>A polymorphism affects the severity of hepatic histological features and nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease 7/6/2021 2:31:17 AM \| Browse: 1053 \| Download: 2811
26	Non-alcoholic fatty liver and chronic kidney disease: Retrospect, introspect, and prospect 4/29/2021 2:12:02 AM \| Browse: 1147 \| Download: 2333
27	Adult human liver slice cultures: Modelling of liver fibrosis and evaluation of new anti-fibrotic drugs 2/25/2021 3:45:30 PM \| Browse: 1144 \| Download: 2430
28	Pleiotropy within gene variants associated with nonalcoholic fatty liver disease and traits of the hematopoietic system 1/25/2021 6:05:27 AM \| Browse: 978 \| Download: 2369
29	Prevalence and risk factors of nonalcoholic fatty liver disease in patients with inflammatory bowel diseases: A cross-sectional and longitudinal analysis 12/14/2020 8:10:05 AM \| Browse: 1212 \| Download: 2785
30	Advances in the treatment of nonalcoholic steatohepatitis 10/29/2020 5:34:30 AM \| Browse: 1492 \| Download: 2479
31	PNPLA3 and TM6SF2 polymorphisms in Brazilian patients with nonalcoholic fatty liver disease 10/24/2020 2:27:20 AM \| Browse: 1365 \| Download: 2581
32	Role of betaine in liver disease-worth revisiting or has the die been cast? 10/14/2020 11:33:23 AM \| Browse: 1018 \| Download: 2194
33	Can gadoxetic acid–enhanced magnetic resonance imaging be used to avoid liver biopsy in patients with nonalcoholic fatty liver disease? 9/21/2020 4:02:08 PM \| Browse: 1034 \| Download: 2976
34	Management of nonalcoholic fatty liver disease in the Middle East 7/7/2020 2:50:53 PM \| Browse: 1428 \| Download: 2128
35	Role of micronutrients in staging of nonalcoholic fatty liver disease: A retrospective cross-sectional study 6/19/2020 9:46:52 AM \| Browse: 1501 \| Download: 2849
36	Natural products that target macrophages in treating non-alcoholic steatohepatitis 5/14/2020 3:43:04 AM \| Browse: 1413 \| Download: 2453
37	L-carnitine supplementation in non-alcoholic fatty liver disease: A systematic review and meta-analysis 2/28/2020 10:08:51 AM \| Browse: 1780 \| Download: 2705
38	Value of controlled attenuation parameter in fibrosis prediction in nonalcoholic steatohepatitis 9/7/2019 4:43:36 AM \| Browse: 1353 \| Download: 2845
39	Biomarkers and subtypes of deranged lipid metabolism in non-alcoholic fatty liver disease 6/28/2019 12:22:27 PM \| Browse: 1737 \| Download: 2959
40	Trimethylamine N-oxide attenuates high-fat high-cholesterol diet-induced steatohepatitis by reducing hepatic cholesterol overload in rats 5/28/2019 9:29:42 AM \| Browse: 1399 \| Download: 3223
41	Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice 3/20/2019 5:32:10 AM \| Browse: 1720 \| Download: 2596
42	Role of cenicriviroc in the management of nonalcoholic fatty liver disease 12/27/2018 8:56:32 AM \| Browse: 1326 \| Download: 2074
43	Current trends of liver cirrhosis in Mexico: Similitudes and differences with other world regions 12/6/2018 1:35:45 PM \| Browse: 1771 \| Download: 3123
44	Treating nonalcoholic steatohepatitis with antidiabetic drugs: Will GLP-1 agonists end the struggle? 11/27/2018 1:56:41 PM \| Browse: 1363 \| Download: 2193
45	Current status of imaging in nonalcoholic fatty liver disease 8/27/2018 12:43:23 PM \| Browse: 1792 \| Download: 2132
46	Helicobacter pylori infection and liver diseases: Epidemiology and insights into pathogenesis 8/27/2018 7:22:43 AM \| Browse: 1530 \| Download: 1915
47	Apoptosis and non-alcoholic fatty liver diseases 7/5/2018 1:33:43 AM \| Browse: 1616 \| Download: 2539
48	Dynamic alterations in the gut microbiota and metabolome during the development of methionine-choline-deficient diet-induced nonalcoholic steatohepatitis 6/15/2018 9:13:16 AM \| Browse: 1588 \| Download: 3263
49	Mouse models for investigating the underlying mechanisms of nonalcoholic steatohepatitis-derived hepatocellular carcinoma 5/11/2018 10:51:26 AM \| Browse: 1164 \| Download: 1947
50	Nonalcoholic steatohepatitis severity is defined by a failure in compensatory antioxidant capacity in the setting of mitochondrial dysfunction 4/27/2018 3:25:40 AM \| Browse: 1704 \| Download: 2239

Page 1 of 3 ( 121 items )
<<
1
2
3
>>

1	Clinicopathological characteristics and risk factors in nonalcoholic steatohepatitis patients with different stages of liver fibrosis 7/24/2026 7:03:49 AM \| Browse: 38 \| Download: 183
2	Noninvasive liver fibrosis assessment in metabolic dysfunction-associated steatotic liver disease 1/27/2026 10:12:30 AM \| Browse: 256 \| Download: 369
3	Quick glance at 'metabolic dysfunction associated steatotic liver disease' therapeutics: Targets, trials, and trends 12/5/2025 11:28:02 AM \| Browse: 197 \| Download: 453
4	Pathological features of non-alcoholic steatohepatitis in a pediatric patient with heterozygous familial hypobetalipoproteinemia: A case report 2/20/2025 8:39:54 AM \| Browse: 331 \| Download: 939
5	Revolutionizing the understanding of liver disease: Metabolism, function and future 11/29/2024 2:50:19 PM \| Browse: 395 \| Download: 1092
6	Regression of hepatic fibrosis after pharmacological therapy for nonalcoholic steatohepatitis 10/25/2024 3:02:15 AM \| Browse: 385 \| Download: 956
7	Potential therapeutic targets for nonalcoholic fatty liver disease: Glucagon-like peptide 1 12/27/2023 5:42:53 AM \| Browse: 549 \| Download: 1673
8	Noninvasive biomarkers in pediatric nonalcoholic fatty liver disease 5/24/2023 9:31:05 AM \| Browse: 652 \| Download: 1571
9	New uses for an old remedy: Digoxin as a potential treatment for steatohepatitis and other disorders 3/28/2023 12:59:29 PM \| Browse: 477 \| Download: 1194
10	Emerging role of engineered exosomes in nonalcoholic fatty liver disease 3/22/2023 11:20:34 AM \| Browse: 705 \| Download: 1795
11	Microbiome-liver crosstalk: A multihit therapeutic target for liver disease 3/17/2023 6:20:53 AM \| Browse: 576 \| Download: 1582
12	Hepatocellular carcinoma in non-alcoholic steatohepatitis without cirrhosis 1/6/2023 2:52:58 AM \| Browse: 722 \| Download: 1271
13	Screening and interventions to prevent nonalcoholic fatty liver disease/nonalcoholic steatohepatitis-associated hepatocellular carcinoma 1/6/2023 2:52:58 AM \| Browse: 730 \| Download: 1538
14	Management of metabolic-associated fatty liver disease: The diabetology perspective 1/4/2023 5:53:02 AM \| Browse: 681 \| Download: 1318
15	Emerging novel targets for nonalcoholic fatty liver disease treatment: Evidence from recent basic studies 1/4/2023 5:53:01 AM \| Browse: 698 \| Download: 1802
16	Dietary counseling based on artificial intelligence for patients with nonalcoholic fatty liver disease 10/28/2022 7:46:25 AM \| Browse: 925 \| Download: 2300
17	Heredity hemochromatosis: Temporal trends, sociodemographic characteristics, and independent risk factor of hepatocellular cancer – nationwide population-based study 9/23/2022 12:48:56 AM \| Browse: 868 \| Download: 2410
18	Nonalcoholic fatty liver disease and diabetes 9/9/2022 3:45:24 PM \| Browse: 1088 \| Download: 2014
19	Simple diagnostic algorithm identifying at-risk nonalcoholic fatty liver disease patients needing specialty referral within the United States 8/26/2022 9:51:35 AM \| Browse: 886 \| Download: 2109
20	Prognostic non-invasive biomarkers for all-cause mortality in non-alcoholic fatty liver disease: A systematic review and meta-analysis 5/24/2022 10:35:19 AM \| Browse: 840 \| Download: 1956
21	Hepatocellular carcinoma in patients with metabolic dysfunction-associated fatty liver disease: Can we stratify at-risk populations? 2/22/2022 9:25:37 AM \| Browse: 999 \| Download: 2275
22	Non-alcoholic steatohepatitis in liver transplant recipients diagnosed by serum cytokeratin 18 and transient elastography: A prospective study 12/27/2021 5:24:01 AM \| Browse: 1024 \| Download: 2500
23	Promising diagnostic biomarkers of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: From clinical proteomics to microbiome 11/24/2021 9:54:22 AM \| Browse: 1117 \| Download: 2230
24	Association of non-alcoholic fatty liver disease and COVID-19: A literature review of current evidence 8/20/2021 9:33:19 AM \| Browse: 1073 \| Download: 2336
25	PPARGC1A rs8192678 G>A polymorphism affects the severity of hepatic histological features and nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease 7/6/2021 2:31:17 AM \| Browse: 1053 \| Download: 2811
26	Non-alcoholic fatty liver and chronic kidney disease: Retrospect, introspect, and prospect 4/29/2021 2:12:02 AM \| Browse: 1147 \| Download: 2333
27	Adult human liver slice cultures: Modelling of liver fibrosis and evaluation of new anti-fibrotic drugs 2/25/2021 3:45:30 PM \| Browse: 1144 \| Download: 2430
28	Pleiotropy within gene variants associated with nonalcoholic fatty liver disease and traits of the hematopoietic system 1/25/2021 6:05:27 AM \| Browse: 978 \| Download: 2369
29	Prevalence and risk factors of nonalcoholic fatty liver disease in patients with inflammatory bowel diseases: A cross-sectional and longitudinal analysis 12/14/2020 8:10:05 AM \| Browse: 1212 \| Download: 2785
30	Advances in the treatment of nonalcoholic steatohepatitis 10/29/2020 5:34:30 AM \| Browse: 1492 \| Download: 2479
31	PNPLA3 and TM6SF2 polymorphisms in Brazilian patients with nonalcoholic fatty liver disease 10/24/2020 2:27:20 AM \| Browse: 1365 \| Download: 2581
32	Role of betaine in liver disease-worth revisiting or has the die been cast? 10/14/2020 11:33:23 AM \| Browse: 1018 \| Download: 2194
33	Can gadoxetic acid–enhanced magnetic resonance imaging be used to avoid liver biopsy in patients with nonalcoholic fatty liver disease? 9/21/2020 4:02:08 PM \| Browse: 1034 \| Download: 2976
34	Management of nonalcoholic fatty liver disease in the Middle East 7/7/2020 2:50:53 PM \| Browse: 1428 \| Download: 2128
35	Role of micronutrients in staging of nonalcoholic fatty liver disease: A retrospective cross-sectional study 6/19/2020 9:46:52 AM \| Browse: 1501 \| Download: 2849
36	Natural products that target macrophages in treating non-alcoholic steatohepatitis 5/14/2020 3:43:04 AM \| Browse: 1413 \| Download: 2453
37	L-carnitine supplementation in non-alcoholic fatty liver disease: A systematic review and meta-analysis 2/28/2020 10:08:51 AM \| Browse: 1780 \| Download: 2705
38	Value of controlled attenuation parameter in fibrosis prediction in nonalcoholic steatohepatitis 9/7/2019 4:43:36 AM \| Browse: 1353 \| Download: 2845
39	Biomarkers and subtypes of deranged lipid metabolism in non-alcoholic fatty liver disease 6/28/2019 12:22:27 PM \| Browse: 1737 \| Download: 2959
40	Trimethylamine N-oxide attenuates high-fat high-cholesterol diet-induced steatohepatitis by reducing hepatic cholesterol overload in rats 5/28/2019 9:29:42 AM \| Browse: 1399 \| Download: 3223
41	Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice 3/20/2019 5:32:10 AM \| Browse: 1720 \| Download: 2596
42	Role of cenicriviroc in the management of nonalcoholic fatty liver disease 12/27/2018 8:56:32 AM \| Browse: 1326 \| Download: 2074
43	Current trends of liver cirrhosis in Mexico: Similitudes and differences with other world regions 12/6/2018 1:35:45 PM \| Browse: 1771 \| Download: 3123
44	Treating nonalcoholic steatohepatitis with antidiabetic drugs: Will GLP-1 agonists end the struggle? 11/27/2018 1:56:41 PM \| Browse: 1363 \| Download: 2193
45	Current status of imaging in nonalcoholic fatty liver disease 8/27/2018 12:43:23 PM \| Browse: 1792 \| Download: 2132
46	Helicobacter pylori infection and liver diseases: Epidemiology and insights into pathogenesis 8/27/2018 7:22:43 AM \| Browse: 1530 \| Download: 1915
47	Apoptosis and non-alcoholic fatty liver diseases 7/5/2018 1:33:43 AM \| Browse: 1616 \| Download: 2539
48	Dynamic alterations in the gut microbiota and metabolome during the development of methionine-choline-deficient diet-induced nonalcoholic steatohepatitis 6/15/2018 9:13:16 AM \| Browse: 1588 \| Download: 3263
49	Mouse models for investigating the underlying mechanisms of nonalcoholic steatohepatitis-derived hepatocellular carcinoma 5/11/2018 10:51:26 AM \| Browse: 1164 \| Download: 1947
50	Nonalcoholic steatohepatitis severity is defined by a failure in compensatory antioxidant capacity in the setting of mitochondrial dysfunction 4/27/2018 3:25:40 AM \| Browse: 1704 \| Download: 2239